Bnp Paribas Asset Management Holding S.A. Royalty Pharma PLC Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 634,501 shares of RPRX stock, worth $19.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
634,501
Previous 399,510
58.82%
Holding current value
$19.4 Million
Previous $10.5 Million
70.38%
% of portfolio
0.04%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding RPRX
# of Institutions
410Shares Held
284MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.26 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$705 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$494 Million0.35% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$372 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...